Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
26 /100
MEDIUM RISK
Score updated Oct 13, 2026

TMCI — Treace Medical Concepts, Inc. Dilution Risk Tracker

Track TMCI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TMCI — Get alerts when the score changes →

As of October 13, 2026, Treace Medical Concepts, Inc. (TMCI) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Treace Medical Concepts, Inc. has a market capitalization of $266.64M, 65.03M shares outstanding, 120 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.97 approaching $1 threshold
🔔 Track TMCI — Get forecast alerts →

Market Data

Market Cap$266.64M
Shares Outstanding65.03M
Float48.00M
Cash$45.62M
Debt$56.04M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore26/100DilutionWatch score record
Shares Outstanding65.03MVerified float table or market cache
Public Float48.00MVerified float table or market cache
Market Cap$266.64MMarket data cache
Cash Runway42.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: 4 5.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 8.4% shares (2026Q1 vs prior)
120 institutional holders · 39.40M shares
#1 ARMISTICE CAPITAL, LLC 6.36M shares
#2 GAGNON SECURITIES LLC 5.20M shares
#3 BlackRock, Inc. 3.34M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.98M
Days to Cover8.6
% of Float4.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-03-11
4 INSIDER TRANSACTION 2026-03-11
4 INSIDER TRANSACTION 2026-03-11
4 INSIDER TRANSACTION 2026-03-11
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TMCI Dilution Snapshot

Treace Medical Concepts, Inc. (TMCI) has a DilutionScore of 26/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TMCI's DilutionScore is currently 26/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 22/100 (Low risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202626/100MEDIUM60 days
Jul 16 – Aug 13, 202622/100LOW29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TMCI shares outstanding have increased 1.8% from 63.72M (Mar 2026) to 64.87M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 27, 202664.87M48.00M▼ 0.62%
May 15, 202664.87M48.30M▲ 0.14%
May 12, 202664.87M48.23M▲ 0.70%
Apr 27, 202664.78M47.90M▼ 0.07%
Apr 24, 202664.78M47.93M▼ 0.03%
Apr 15, 202664.78M47.95M▼ 0.02%
Apr 11, 202664.78M47.95M▲ 0.10%
Mar 19, 202664.59M47.91M▲ 1.25%
Mar 05, 202663.72M47.32M▲ 0.32%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TMCI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TMCI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TMCI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TMCI
TMCI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.